Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPH
2726
DELISTED
Tri Pointe Homes
TPH
| $11.9M | ﹤0.01% |
329,318
-107,162
| -25% | -$4.47M |
|
2727
Mettler-Toledo International
MTD
$28B
| $11.9M | ﹤0.01% |
9,750
+9,641
| +8,845% | +$12.6M |
|
2728
Blend Labs
BLND
$360M
| $11.9M | ﹤0.01% |
2,833,486
+2,217,504
| +360% | +$9.54M |
|
2729
NexGen Energy
NXE
$7.28B
| $11.9M | ﹤0.01% |
1,805,994
+1,258,122
| +230% | +$9.49M |
|
2730
Euronet Worldwide
EEFT
$2.62B
| $11.9M | ﹤0.01% |
115,872
+57,269
| +98% | +$5.83M |
|
2731
Deere & Co
DE
$175B
| $11.9M | ﹤0.01% |
+28,121
| New | +$11.8M |
|
2732
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.8B
| $11.9M | ﹤0.01% |
237,625
-30,817
| -11% | -$1.56M |
|
2733
CALL
Impinj
PI
$5.06B
| $11.9M | ﹤0.01% |
82,000
+23,400
| +40% | +$4.44M |
|
2734
PagerDuty
PD
$950M
| $11.9M | ﹤0.01% |
652,289
+234,118
| +56% | +$4.49M |
|
2735
CALL
Southern Copper
SCCO
$182B
| $11.9M | ﹤0.01% |
139,615
-23,114
| -14% | -$2.28M |
|
2736
PUT
Vanguard High Dividend Yield ETF
VYM
$83.2B
| $11.9M | ﹤0.01% |
93,200
+28,900
| +45% | +$3.77M |
|
|
ECHO
2737
CALL
EchoStar
ECHO
$25.2B
| $11.9M | ﹤0.01% |
518,875
+9,875
| +2% | +$239K |
|
2738
OR Royalties Inc
OR
$6.76B
| $11.8M | ﹤0.01% |
654,471
+43,626
| +7% | +$849K |
|
|
JWN
2739
DELISTED
Nordstrom
JWN
| $11.8M | ﹤0.01% |
490,288
-1,535,898
| -76% | -$35.5M |
|
|
NARI
2740
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $11.8M | ﹤0.01% |
231,696
+60,939
| +36% | +$3M |
|
2741
PUT
Dover
DOV
$27.2B
| $11.8M | ﹤0.01% |
63,000
+27,100
| +75% | +$5.3M |
|
2742
Phinia Inc
PHIN
$2.67B
| $11.8M | ﹤0.01% |
+245,115
| New | +$12.1M |
|
2743
CALL
XPeng
XPEV
$11.7B
| $11.8M | ﹤0.01% |
998,200
-13,000
| -1% | -$161K |
|
2744
PUT
Yeti Holdings
YETI
$3.19B
| $11.8M | ﹤0.01% |
306,100
-11,800
| -4% | -$469K |
|
2745
National Beverage
FIZZ
$3.03B
| $11.8M | ﹤0.01% |
275,606
+59,162
| +27% | +$2.76M |
|
2746
PUT
Coupang
CPNG
$29.6B
| $11.8M | ﹤0.01% |
535,000
-252,800
| -32% | -$6.2M |
|
2747
CALL
State Street
STT
$51.4B
| $11.8M | ﹤0.01% |
119,800
-57,000
| -32% | -$5.4M |
|
2748
BlackLine
BL
$1.85B
| $11.8M | ﹤0.01% |
193,440
-107,821
| -36% | -$6.43M |
|
|
2749
CALL
Mettler-Toledo International
MTD
$28B
| $11.7M | ﹤0.01% |
9,600
+500
| +5% | +$652K |
|
2750
PUT
Freshpet
FRPT
$3.55B
| $11.7M | ﹤0.01% |
79,200
-22,600
| -22% | -$3.29M |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.